Industry
Biotechnology
Topic
All Topics
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Biotechnology
... Gene-editing technology CRISPR has revealed a clue in how human embryos begin to develop, possibly ...
... approach to making drugs. I sat down with Vivek Ramaswamy, CEO of Roivant Sciences, and four CEOs of his member companies to chat about the ...
... Arroyo LLP is investigating whether certain officers and directors of Juno Therapeutics, Inc. (NASDAQGS: JUNO) breached their fiduciary duty to shareholders by engaging in self-dealing ...
... NantKwest, Inc. (Nasdaq:NK) today announced that Fred Driscoll, currently an Advisor and former Chief ...
... WATERTOWN, Mass., Sept. 22, 2017 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug products ...
... Steep Hill Labs, Inc.,the global industry leader in cannabis testing and analytics, today released ...
... AUSTIN, Texas, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and ...
... Mexican technology. The University of New Mexico announced on Wednesday that Pascal Biosciences Inc., a drug discovery and development company, would acquire a "therapeutic monoclonal ...
... LEXINGTON, Mass., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative ...
... PHILADELPHIA and OXFORD, U.K., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced ...
... China and CUPERTINO, Calif., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a clinical-stage biopharmaceutical firm engaged in ...
... Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced ...
... AG, Som Phytopharma India Limited, Syngenta, International Panaacea Ltd, The Stockton Group, BioWorks, Inc., Novozymes, Inc., Koppert B.V., W. Neudorff GMBH KG, in vivo, Valent ...
... these four stocks are being assessed: ImmunoCellular Therapeutics Ltd (NYSEMKT: IMUC), Protalix BioTherapeutics Inc. (NYSEMKT: PLX), Synthetic Biologics Inc. (NYSEMKT: SYN), and Abeona Therapeutics Inc. ...
... CANADIAN RESULTS P&P Ventures (TSXV:PPV.H) reported EPS for the half year-ended 30 June 2017 of ...
... Juno Therapeutics, Inc.(NASDAQ: JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment ...
... to which the Company will acquire all of the shares of Novoheart Holdings Ltd. ("Novoheart") (the "Transaction"). The Transaction constitutes a "reverse take-over" of Woodrose ...
... GAITHERSBURG - Novavax, Inc., (Nasdaq:NVAX) today announced the enrollment of the first participant in a ...
... Barcelona (Catalonia, Spain) - Ability Pharmaceuticals, a drug development biopharmaceutical company specialized in oncology, announced today that ...
... CAMBRIDGE, Mass - Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies, today ...
... Institute, in collaboration with colleagues at Cambridge University, Oxford University, the Wellcome Trust Sanger Institute, Seoul National University and Bourn Hall Clinic. It was chiefly ...
... development, and ultimately save lives," May continued. Incubated by Ramaswamy’s parent company Roivant, Datavant says it “has already compiled data from 85 different datasets comprising ...
... concern for consumers, and in response to that demand international ingredient supplier, Ganeden, recently developed a new immune-health solution called Staimune(TM). Now, the company is ...
... position) and to the restructuring costs incurred by Genkyotex SA (formerly called Genticel SA). As at June 30, 2017, Genkyotex had cash, cash equivalents and ...
... toxicity. This research program is being funded in part by the National Cancer Institute. Radiation therapy or radiotherapy plays an important role in the fight ...
... Merz North America, Inc. announced today that Merz has been recognized by Aesthetic Everything® ...
... Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy ...
... shareholders nationwide, is investigating potential breach of fiduciary duty claims against NantKwest, Inc. (NASDAQGS: NK) ("NantKwest" or the "Company"). If you currently own shares of ...
... AUSTIN, Texas, Sept. 21, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that management will be presenting at Cantor Fitzgerald's Global ...
... Provention Bio, Inc., a clinical stage biopharmaceutical company dedicated to sourcing, developing and commercializing ...
... Parallax Health Sciences, Inc. ("Parallax" or the "Company") (PRLX), and its wholly-owned subsidiary Parallax Behavioral ...
... RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2017 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) a biotechnology company focused on the development and commercialization of ...
... MELBOURNE, Australia, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) ("Company"), a molecular diagnostics company specialising in cancer genomics, ...
... Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed ...
... Phelps and Caleb Skeath, $899,900. Randolph Ave. E., 117-E. Randolph Corp. A. Virginia Limited Liabil to 117 Randolph Ave Corp. A. Virginia Limited, $542,000. Roberts ...
... Witty, the former chief executive of GLAXOSMITHKLINE, has joined the board of Synthego, a genetic engineering start-up, with the appointment coming a day after he ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤